<DOC>
	<DOCNO>NCT01959542</DOCNO>
	<brief_summary>In research study , investigator try determine measurable change prostate MRI help predict respond Androgen Deprivation Therapy ( ADT ) External Beam Radiation Therapy ( EBRT ) The first baseline prostate MRI prior start treatment standard care . The participant 's ADT/EBRT treatment also standard care , advise doctor . It 3 follow prostate MRIs ADT/EBRT treatment , 4 follow serum PSA level part research study .</brief_summary>
	<brief_title>Early Changes In Multiparametric MRI In Prostate Cancer</brief_title>
	<detailed_description>If participant chooses take part research study , participant 3 follow prostate MRIs 6 month time period , participant ADT/EBRT treatment . These follow-up prostate MRIs use standard image protocol without use endorectal coil . The participant also total 4 blood sample measure serum PSA . 1-2 ml ( less ½ teaspoon ) take sample . Research Study Plan - Baseline Visit ( routine standard care screen visit ) : PSA blood test prostate MRI - Visit 1 ( 8 week start ADT ) : PSA blood test prostate MRI - Visit 2 ( 6 week start EBRT ) : PSA blood test prostate MRI - Visit 3 ( last day EBRT ) : PSA blood test - Visit 4 ( 6 month start ADT ) : PSA blood test prostate MRI Planned Follow-up : The investigator would like keep track participant 's prostate cancer status continue see doctor DFCI . The investigator would like collect follow data participant 's medical record , look long-term outcome ADT/EBRT treatment . - PSA value - Clinical result treatment . The investigator contact participant obtain information .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Adult male unfavorable intermediate highrisk localize disease , define one follow three category , Clinical radiographic T2bT4 primary tumor Gleason score 710 core , PSA ≥ 10 prior initiation therapy Patients deem suitable therapy ADT EBRT . Subjects must able provide informed write consent prior study entry . The standard exclusion criterion MRI exams apply include patient pacemaker , noncompatible intracranial vascular clip , inner ear implant , severe claustrophobia . Patients age , general medical psychiatric condition , physiologic status unrelated presence prostate cancer unlikely candidate repeat MRIs , give valid inform consent . Patients unwilling unable undergo multiparametric MRI exam ( nonendorectal coil ) . Patients history allergic reaction latex Gadolinium contain intravenous contrast agent . Individuals renal disease contraindication gadolinium exclude . The BWH standard MRI contrast screen criterion use establish renal status . Patients prior prostatectomy prior androgen therapy . Patients hip implant metallic implant device result significant distortion local magnetic field compromise quality multiparametric MRI data .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Prostate Cancer</keyword>
</DOC>